Saori Hatachi
About
In The Last Decade
Saori Hatachi
24 papers receiving 531 citations
Peers
Comparison fields: 5 of 80
- Immunology 221
- Rheumatology 141
- Oncology 126
- Molecular Biology 93
- Epidemiology 90
Countries citing papers authored by Saori Hatachi
This map shows the geographic impact of Saori Hatachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saori Hatachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saori Hatachi more than expected).
Fields of papers citing papers by Saori Hatachi
This network shows the impact of papers produced by Saori Hatachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saori Hatachi. The network helps show where Saori Hatachi may publish in the future.
Co-authorship network of co-authors of Saori Hatachi
This figure shows the co-authorship network connecting the top 25 collaborators of Saori Hatachi. A scholar is included among the top collaborators of Saori Hatachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saori Hatachi. Saori Hatachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 10 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 8 | |
| 8 | 12 | |
| 9 | 73 | |
| 10 | 16 | |
| 11 | 7 | |
| 12 | 13 | |
| 13 | 9 | |
| 14 | 10 | |
| 15 | 6 | |
| 16 | 31 | |
| 17 | Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome. | 68 |
| 18 | [Natural killer cell activity, activity of lymphokine-activated killer cells (LAK activity), and killer-helper factors (KHF)]. | 0 |
| 19 | 55 | |
| 20 | CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. | 83 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.